bevacizumab
roche
[' bev ']
 so only 3 % got maintenance bev and 17 % got maintenance parp . seems very low by any standard. is that contributing to os ?
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists